GILEAD SCIENCES, INC. Cash and Cash Equivalents, Period Increase (Decrease)
GILEAD SCIENCES, INC. (GILD) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$6.70 billion for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-08-06
- GILEAD SCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$5.69B, a 201.72% decline year-over-year.
- GILEAD SCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$1.01B, a 1941.82% decline year-over-year.
- GILEAD SCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $3.37B.
- GILEAD SCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $1.33B, a 52.25% decline year-over-year.
- GILEAD SCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $10.35B.
- GILEAD SCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$641.00M.
- GILEAD SCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$4.62B, a 263.67% decline from fiscal 2015.
- GILEAD SCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $2.82B, a 64.32% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$5.69B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$6.70B 10-Q · filed 2019-08-06 | -$3.33B derived: sum of 3 quarters · filed 2019-08-06 | -$1.99B derived: sum of 4 quarters · filed 2019-08-06 | ||||
| 2019-03-31 | -$1.01B 10-Q · filed 2019-05-08 | $2.36B derived: sum of 2 quarters · filed 2019-05-08 | $3.69B derived: sum of 3 quarters · filed 2019-05-08 | $9.28B derived: sum of 4 quarters · filed 2019-08-06 | ||||
| 2018-12-31 | $3.37B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $4.71B derived: sum of 2 quarters · filed 2019-02-26 | $10.30B derived: sum of 3 quarters · filed 2019-08-06 | $10.35B 10-K · filed 2019-02-26 | ||||
| 2018-09-30 | $1.33B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $6.93B derived: sum of 2 quarters · filed 2019-08-06 | $6.98B 10-Q · filed 2018-11-06 | $3.06B derived: sum of 4 quarters · filed 2019-08-06 | ||||
| 2018-06-30 | $5.59B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.65B 10-Q · filed 2019-08-06 | $1.73B derived: sum of 3 quarters · filed 2019-08-06 | $4.52B derived: sum of 4 quarters · filed 2019-08-06 | ||||
| 2018-03-31 | $55.00M 10-Q · filed 2019-05-08 | -$3.87B derived: sum of 2 quarters · filed 2019-05-08 | -$1.07B derived: sum of 3 quarters · filed 2019-05-08 | -$2.64B derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | -$3.92B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$1.12B derived: sum of 2 quarters · filed 2019-02-26 | -$2.70B derived: sum of 3 quarters · filed 2019-02-26 | -$641.00M 10-K · filed 2019-02-26 | ||||
| 2017-09-30 | $2.80B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.22B derived: sum of 2 quarters · filed 2018-11-06 | $3.28B 10-Q · filed 2018-11-06 | $1.70B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | -$1.57B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $483.00M 10-Q · filed 2018-08-06 | -$1.10B derived: sum of 3 quarters · filed 2019-02-26 | $2.23B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $2.06B 10-Q · filed 2018-05-09 | $476.00M derived: sum of 2 quarters · filed 2019-02-26 | $3.80B derived: sum of 3 quarters · filed 2019-02-26 | $3.97B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$1.58B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.74B derived: sum of 2 quarters · filed 2019-02-26 | $1.91B derived: sum of 3 quarters · filed 2019-02-26 | -$4.62B 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $3.32B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.49B derived: sum of 2 quarters · filed 2017-11-07 | -$3.04B 10-Q · filed 2017-11-07 | -$4.16B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $170.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$6.37B 10-Q · filed 2017-08-07 | -$7.48B derived: sum of 3 quarters · filed 2018-02-27 | -$932.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | -$6.54B 10-Q · filed 2017-05-10 | -$7.65B derived: sum of 2 quarters · filed 2018-02-27 | -$1.10B derived: sum of 3 quarters · filed 2018-02-27 | -$4.32B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$1.11B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $5.43B derived: sum of 2 quarters · filed 2018-02-27 | $2.22B derived: sum of 3 quarters · filed 2018-02-27 | $2.82B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $6.55B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $3.33B derived: sum of 2 quarters · filed 2016-11-07 | $3.94B 10-Q · filed 2016-11-07 | $7.76B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | -$3.22B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$2.61B 10-Q · filed 2016-08-05 | $1.21B derived: sum of 3 quarters · filed 2017-02-27 | -$1.31B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $608.00M 10-Q · filed 2016-05-06 | $4.43B derived: sum of 2 quarters · filed 2017-02-27 | $1.90B derived: sum of 3 quarters · filed 2017-02-27 | $4.23B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $3.82B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.30B derived: sum of 2 quarters · filed 2017-02-27 | $3.62B derived: sum of 3 quarters · filed 2017-02-27 | $7.91B 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | -$2.52B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$195.00M derived: sum of 2 quarters · filed 2015-11-04 | $4.10B 10-Q · filed 2015-11-04 | $4.10B 10-Q · filed 2014-11-05 | $4.20B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $2.33B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $6.62B 10-Q · filed 2015-08-05 | $6.62B 10-Q · filed 2014-08-04 | $6.72B derived: sum of 3 quarters · filed 2016-02-24 | $6.53B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | $4.29B 10-Q · filed 2015-05-08 | $4.29B 10-Q · filed 2014-05-07 | $4.39B derived: sum of 2 quarters · filed 2016-02-24 | $4.20B derived: sum of 3 quarters · filed 2016-02-24 | $4.54B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $101.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$89.48M derived: sum of 2 quarters · filed 2016-02-24 | $248.72M derived: sum of 3 quarters · filed 2016-02-24 | $309.00M 10-K · filed 2016-02-24 | $309.11M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | -$191.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $146.76M derived: sum of 2 quarters · filed 2014-11-05 | $207.04M 10-Q · filed 2014-11-05 | $460.11M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $338.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $398.48M 10-Q · filed 2014-08-04 | $651.55M derived: sum of 3 quarters · filed 2015-02-25 | $576.76M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $60.28M 10-Q · filed 2014-05-07 | $313.35M derived: sum of 2 quarters · filed 2015-02-25 | $238.56M derived: sum of 3 quarters · filed 2015-02-25 | $412.11M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $253.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $178.28M derived: sum of 2 quarters · filed 2015-02-25 | $351.83M derived: sum of 3 quarters · filed 2015-02-25 | -$8.08B 10-K · filed 2015-02-25 | -$8.08B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | -$74.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $98.77M derived: sum of 2 quarters · filed 2013-10-31 | -$8.33B 10-Q · filed 2013-10-31 | $641.35M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $173.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$8.26B 10-Q · filed 2013-08-01 | $716.14M derived: sum of 3 quarters · filed 2014-02-25 | $719.72M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$8.43B 10-Q · filed 2013-05-08 | $542.58M derived: sum of 2 quarters · filed 2014-02-25 | $546.16M derived: sum of 3 quarters · filed 2014-02-25 | -$384.04M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $8.97B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $8.98B derived: sum of 2 quarters · filed 2014-02-25 | $8.05B derived: sum of 3 quarters · filed 2014-02-25 | $8.98B 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$926.62M derived: sum of 2 quarters · filed 2012-11-06 | $1.48M 10-Q · filed 2012-11-06 | -$113.63M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | -$930.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | -$2.10M 10-Q · filed 2012-08-01 | -$117.21M derived: sum of 3 quarters · filed 2013-02-27 | -$576.86M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $928.10M 10-Q · filed 2012-05-04 | $812.99M derived: sum of 2 quarters · filed 2013-02-27 | $353.34M derived: sum of 3 quarters · filed 2013-02-27 | $899.10M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | -$115.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$574.76M derived: sum of 2 quarters · filed 2013-02-27 | -$29.00M derived: sum of 3 quarters · filed 2013-02-27 | -$365.08M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | -$459.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $86.11M derived: sum of 2 quarters · filed 2011-11-04 | -$249.97M 10-Q · filed 2011-11-04 | -$1.61M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $545.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $209.68M 10-Q · filed 2011-08-05 | $458.04M derived: sum of 3 quarters · filed 2012-02-23 | $441.76M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | -$336.08M 10-Q · filed 2011-05-09 | -$87.72M derived: sum of 2 quarters · filed 2012-02-23 | -$103.99M derived: sum of 3 quarters · filed 2012-02-23 | -$726.77M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $248.36M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $232.08M derived: sum of 2 quarters · filed 2012-02-23 | -$390.69M derived: sum of 3 quarters · filed 2012-02-23 | -$186.34M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | -$16.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$639.05M derived: sum of 2 quarters · filed 2010-11-08 | -$434.70M 10-Q · filed 2010-11-08 | -$184.82M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | -$622.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | -$418.43M 10-Q · filed 2010-08-09 | -$168.55M derived: sum of 3 quarters · filed 2011-02-28 | -$78.72M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $204.34M 10-Q · filed 2010-05-10 | $454.22M derived: sum of 2 quarters · filed 2011-02-28 | $544.05M derived: sum of 3 quarters · filed 2011-02-28 | |||||
| 2008-12-31 | $249.88M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $339.70M derived: sum of 2 quarters · filed 2011-02-28 | $491.22M 10-K · filed 2011-02-28 | |||||
| 2008-09-30 | $89.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $241.34M 10-Q · filed 2009-11-05 | ||||||
| 2008-06-30 | $151.51M 10-Q · filed 2009-08-05 | |||||||
| 2007-12-31 | $152.08M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |